UNIGE document Scientific Article - Review
previous document  unige:147398  next document
add to browser collection

Role of in vivo and in vitro Tests in the Diagnosis of Severe Cutaneous Adverse Reactions (SCAR) to Drug

Published in Current pharmaceutical design. 2019, vol. 25, no. 36, p. 3872-3880
Abstract Severe cutaneous adverse reactions (SCAR) are life-threatening conditions including acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson Syndrome (SJS), toxic epidermal necrolysis (TEN) and drug reaction with eosinophilia and systemic symptoms (DRESS). Diagnosis of causative underlying drug hypersensitivity (DH) is mandatory due to the high morbidity and mortality upon re-exposure with the incriminated drug. If an underlying DH is suspected, in vivo test, including patch tests (PTs), delayed-reading intradermal tests (IDTs) and in vitro tests can be performed in selected patients for which the suspected culprit drug is mandatory, or in order to find a safe alternative treatment. Positivity of in vivo and in vitro tests in SCAR to drug varies depending on the type of reaction and the incriminated drugs. Due to the severe nature of these reactions, drug provocation test (DPT) is highly contraindicated in patients who experienced SCAR. Thus, sensitivity is based on positive test results in patients with a suggestive clinical history. Patch tests still remain the first-line diagnostic tests in the majority of patients with SCAR, followed, in case of negative results, by delayed-reading IDTs, with the exception of patients with bullous diseases where IDTs are still contra-indicated. In vitro tests have shown promising results in the diagnosis of SCAR to drug. Positivity is particularly high when the lymphocyte transformation test (LTT) is combined with cytokines and cytotoxic markers measurement (cyto-LTT), but this still has to be confirmed with larger studies. Due to the rarity of SCAR, large multi-center collaborative studies are needed to better study the sensitivity and specificity of in vivo and in vitro tests.
Keywords CytokinesDermatitis, Atopic/diagnosisDrug Hypersensitivity/diagnosisDrug Hypersensitivity SyndromeHumansSensitivity and SpecificitySkin/pathologyStevens-Johnson Syndrome
PMID: 31696801
Full text
Article (Published version) (1 MB) - private document Private access
Research group Pathogenèse et traitement des allergies alimentaires (191)
(ISO format)
BERGMANN, Marcel, CAUBET, Jean-Christoph Roger J-P. Role of in vivo and in vitro Tests in the Diagnosis of Severe Cutaneous Adverse Reactions (SCAR) to Drug. In: Current Pharmaceutical Design, 2019, vol. 25, n° 36, p. 3872-3880. doi: 10.2174/1381612825666191107104126 https://archive-ouverte.unige.ch/unige:147398

106 hits

0 download


Deposited on : 2021-01-14

Export document
Format :
Citation style :